CI Stock Recent News

The Cigna Group's Q3 2024 results showed once again strong revenue and earnings growth. Yet, CI shares are down almost 20% from their 52-week-high. In this article, I will discuss the reasons for the once again favorable valuation of CI stock and explain why I seized what I believe to be a compelling opportunity. I will also give my opinion on the renewed speculation about a possible merger with Humana and explain why the concerns are likely unfounded.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Infirmary's hospitals, facilities and doctors on Alabama's Gulf Coast are now in-network for Cigna Healthcare MA customers MOBILE, Ala. , Nov. 1, 2024 /PRNewswire/ -- Cigna Healthcare and Mobile-based Infirmary Health have reached an agreement that allows Cigna Healthcare's Medicare Advantage (MA) customers to have in-network access to Infirmary Health's hospitals, facilities and doctors.

The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

The Cigna Group (NYSE:CI ) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Ralph Giacobbe - Senior Vice President of Investor Relations David Cordani - Chairman and Chief Executive Officer Brian Evanko - Chief Financial Officer and President and Chief Executive Officer, Cigna Healthcare Eric Palmer - President and Chief Executive Officer, Evernorth Health Services Conference Call Participants AJ Rice - UBS Justin Lake - Wolfe Research Ryan Langston - TD Cowen Lisa Gill - JPMorgan Andrew Mok - Barclays Erin Wright - Morgan Stanley Scott Fidel - Stephens Adam Ron - Bank of America George Hill - Deutsche Bank Josh Raskin - Nephron Research Lance Wilkes - Bernstein Michael Ha - Baird Operator Ladies and gentlemen, thank you for standing by for the Cigna Group's Third Quarter 2024 Results Review. At this time all callers are in a listen-only mode.

CI's strong third-quarter results benefit from a strong Evernorth Health Services segment. Higher expenses partially offset the positives.

Cigna (CI) came out with quarterly earnings of $7.51 per share, beating the Zacks Consensus Estimate of $7.22 per share. This compares to earnings of $6.77 per share a year ago.

Cigna beat Wall Street estimates for third-quarter profit on Thursday, as its unit that runs the pharmacy benefit management business added new clients and saw strong demand for close copies of a blockbuster arthritis drug.

Total revenues for the third quarter 2024 increased 30% to $63.7 billion Shareholders' net income for the third quarter 2024 was $0.7 billion, or $2.63 per share Adjusted income from operations1 for the third quarter 2024 was $2.1 billion, or $7.51 per share Reaffirms 2024 outlook2 for adjusted income from operations1,2 of at least $28.40 per share BLOOMFIELD, Conn. , Oct. 31, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today reported strong third quarter 2024 results demonstrating focused execution across Evernorth Health Services and Cigna Healthcare.

The Cigna Group reported a $739 million third quarter profit despite a $1 billion loss on its investment in clinic operator VillageMD.